PX20606 is an orally active farnesoid X receptor (FXR) agonist that induces the expression of the tumor suppressor gene NDRG2, inhibits tumor growth and metastasis in a mouse hepatocellular carcinoma (HCC) model, and exhibits hepatoprotective activity.